Wall Street Analysts Look Bullish on Axon (AXON): Should You Buy?

Axon Enterprise (AXON) currently holds an average brokerage recommendation (ABR) of 1.43, approximating a rating between Strong Buy and Buy, based on ratings from 15 brokerage firms; however, the article suggests caution, as brokerage recommendations may be biased and are not always reliable indicators of future stock performance. The Zacks Rank, driven by earnings estimate revisions, is presented as a potentially more reliable indicator, and currently assigns Axon a Rank #3 (Hold), with the consensus earnings estimate for the current year remaining unchanged at $6.34.

Analysis

Axon Enterprise (AXON) presents a mixed outlook based on differing analytical tools. Wall Street analysts, through an Average Brokerage Recommendation (ABR) of 1.43 derived from 15 brokerage firms, signal a strong inclination towards 'Strong Buy' or 'Buy'. Specifically, 10 firms rate AXON as a 'Strong Buy' (66.7%) and three as 'Buy' (20%). However, the article cautions against relying solely on ABRs, citing potential positive bias from brokerage firms due to vested interests, noting that for every 'Strong Sell', five 'Strong Buy' recommendations are typically issued. In contrast, the Zacks Rank, a proprietary model driven by earnings estimate revisions, currently assigns AXON a #3 (Hold). This rating is influenced by the Zacks Consensus Estimate for Axon's current year earnings remaining unchanged at $6.34 over the past month. This stability in earnings estimates suggests that analysts' views on the company's earnings prospects are steady, potentially leading the stock to perform in line with the broader market in the near term. The article underscores that the Zacks Rank is often more timely and less prone to the biases affecting ABRs, as it directly reflects changes in earnings estimate revisions, which are empirically correlated with near-term stock price movements.

Key Decisions for Investors

• Investors should exercise caution regarding the bullish Average Brokerage Recommendation (ABR) for Axon, given the potential for inherent positive bias in sell-side analyst ratings.
• The Zacks Rank #3 (Hold) for Axon, coupled with an unchanged consensus earnings estimate of $6.34 for the current year, suggests the stock may track broader market performance in the near term, warranting a neutral stance.
• Consider prioritizing earnings estimate trends and tools like the Zacks Rank over ABRs when assessing Axon's near-term investment potential, due to the former's stronger correlation with stock price movements and timeliness.